World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
80
Citations
22007
World Ranking
4100
National Ranking
300

Ivan D. Horak publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Ivan D. Horak sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 379 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Ivan D. Horak D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ivan D. Horak sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 80 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Ivan D. Horak is affiliated with Freie Universität Berlin in Germany. Their research primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a focus on Oncology, Molecular Biology, Immunology, Pathology and Forensic Medicine, and Genetics.

The main topics of Ivan D. Horak's scientific contributions include:

  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Lymphoma Diagnosis and Treatment
  • HER2/EGFR in Cancer Research
  • Colorectal Cancer Treatments and Studies
  • Cancer Genomics and Diagnostics
  • Biosimilars and Bioanalytical Methods

Frequent co-authors collaborating with Ivan D. Horak are:

  • Kar Wai Tan
  • Lionel Low
  • Fiona HS Wong
  • Aung Myo
  • Lindsay Kua

Ivan D. Horak has contributed to publications in several scientific venues. The most frequent among these include:

  • Blood
  • Regular and Young Investigator Award Abstracts
  • Cancer Research
  • Biotechnologia Acta
  • Science Translational Medicine

Notable recent papers authored or co-authored by Ivan D. Horak include:

  • Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype, 2020, Science Translational Medicine
  • Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer, 2021, European Journal of Cancer
  • Updated Results and Correlative Analysis: Autologous CD30.CAR-T-Cell Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (CHARIOT Trial), 2022, Blood
  • Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs, 2020, Breast Cancer Research
  • Deep neural networks identify signaling mechanisms of ErbB-family drug resistance from a continuous cell morphology space, 2021, Cell Reports

Best Publications

  • Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

    Benjamin Sadlack;Hartmut Merz;Hubert Schorle;Anneliese Schimpl

  • Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting.

    Hubert Schorle;Thomas Holtschke;Thomas Hünig;Anneliese Schimpl

  • Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene.

    Thomas Holtschke;Jürgen Löhler;Yuka Kanno;Thomas Fehr

  • Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.

    I. Magrath;M. Adde;Aziza Shad;D. Venzon

  • Immune responses in interleukin-2-deficient mice

    Thomas M. Kündig;Hubert Schorle;Martin F. Bachmann;Hans Hengartner

  • Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.

    Judith E. Karp;Jeffrey E. Lancet;Scott H. Kaufmann;David W. End

  • Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells

    Benjamin Sadlack;Jürgen Löhler;Hubert Schorle;Gabriele Klebb

  • Sialylation is essential for early development in mice.

    Martina Schwarzkopf;Klaus-Peter Knobeloch;Elvira Rohde;Stephan Hinderlich

  • Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn.

    I Stefanová;M L Corcoran;E M Horak;L M Wahl

  • Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer.

    J. Zujewski;I.D. Horak;C.J. Bol;R. Woestenborghs

  • Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma

    Rhona Stein;Zhengxing Qu;Susan Chen;Adriane Rosario

  • A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth

    Lee M. Greenberger;Ivan D. Horak;David Filpula;Puja Sapra

  • Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.

    Susan J. Knox;Michael L. Goris;Margaret Tempero;Paul L. Weiden

  • The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia

    TA Waldmann;JD White;CK Goldman;L Top

  • T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck.

    Ivan D. Horak;Ronald E. Gress;Phillip J. Lucas;Eva M. Horak

  • Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice

    Wolfgang Hauser;Klaus-Peter Knobeloch;Martin Eigenthaler;Stepan Gambaryan

  • IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation

    Michael Schultz;Susan L. Tonkonogy;Range K. Sellon;Claudia Veltkamp

  • Combination Antibody Therapy With Epratuzumab and Rituximab in Relapsed or Refractory Non-Hodgkin's Lymphoma

    John P. Leonard;Morton Coleman;Jamie Ketas;Michelle Ashe

  • Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias

    Manuel Schmidt;Stefan Nagel;Jutta Proba;Christian Thiede

  • Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.

    Puja Sapra;Hong Zhao;Mary Mehlig;Jennifer Malaby

Frequent Co-Authors

David M. Goldenberg
David M. Goldenberg Immunomedics (United States)
Hans J. Hansen
Hans J. Hansen Eisai (Japan)
Chien-Hsing Chang
Chien-Hsing Chang Northwestern University
Hubert Schorle
Hubert Schorle University Hospital Bonn
Gary L. Griffiths
Gary L. Griffiths National Institutes of Health
Robert M. Sharkey
Robert M. Sharkey University of Fukui
Edmund A. Rossi
Edmund A. Rossi Immunomedics (United States)
Joseph B. Bolen
Joseph B. Bolen Takeda (Japan)
Thomas Wirth
Thomas Wirth University of Ulm
Axel Rethwilm
Axel Rethwilm University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in expanding your future opportunities with a degree in Biology or Biochemistry, exploring related online programs can open new doors. Graduates in these fields often pursue careers not only in research but also in healthcare, nutrition, public health, or administration.

For those passionate about the intersection of biology and human wellness, a best online nutrition degree offers flexible pathways for careers in dietetics, wellness coaching, or public health. If you aim to move into healthcare management, a cahme accreditation mha programs ensures that your Master of Health Administration education meets rigorous standards and boosts your leadership potential.

Advanced practice nurses looking to impact healthcare systems might consider a dnp program without clinical hours, allowing for flexible study while advancing skills in evidence-based practice and healthcare improvement. Likewise, professionals aspiring to executive roles in healthcare organizations may benefit from a doctorate in healthcare management to build strategic leadership and policy expertise.

These online degrees provide diverse options for biology and biochemistry graduates to specialize and grow in today’s rapidly evolving healthcare landscape.

Best Scientists Citing Ivan D. Horak

Trending Scientists

Recently Published Articles